Meaningful Treatment Benefit from the Patient’s Perspective
Instant download of paper http://bit.ly/patient-perspective
Have you been told by the U.S. Food and Drug Administration (FDA) to include the patient’s perspective about treatment benefit in your drug development program? If so, were you prepared to provide it?
Evidera’s recent paper regarding the patients’ perspective on clinical trial treatment benefits provides insights into why this feedback is so important and how to obtain it.
- With the 21st Century Cures Act, there is an increased focus on the patient’s perspective and now, more than ever, regulators are seeking feedback from patients throughout the drug development process
- Concepts being evaluated from the patient’s perspective should be meaningful and relevant to the patients
- Qualitative research can be conducted to evaluate a meaningful treatment benefit both before and during clinical trial implementation
Download this white paper for more information on this topic.
Instant download: http://bit.ly/patient-perspective